For those of you who may be interested following is some latte news Re: PD and fetal transplant.....ED H WASHINGTON (AP) -- The Federal government on Tuesday approved the first grant for fetal tissue research since President Clinton lifted a 5-year-old ban on studies using cells from aborted fetuses. The NINDS is giving $4.5 million to three institutions to study the effects of implanting fetal tissue into the brains of patients with Parkinson's disease. Dr. Patricia Grady, head of the federal institute, said there may be more grants this year, both for Parkinson's and other brain disorders. She called the Parkinson's research promising."We are optimistic it will be helpful for at least some of the patients," she said. Presidents Reagan and Bush banned such research. But Clinton lifted the ban in one of his first official acts. Some privately funded research continued at the University of Colorado and at Yale University throughout the five-year ban, but experts said those studies lacked adequate scientific precision. Parkinson's is a progressive rain disorder that causes tremors, a shuffling walk, a decreased ability to control speech and facial muscles, and a gradual loss of functional control. Its precise cause is unknown, but it is connected to the death of brain cells that produce dopamine, a chemical key to communication within the brain. About 500,000 Americans, most of them over 60, have Parkinson's. There is no cure, but treatment with levodopa, or L-dopa, a chemical that partially mimics dopamine, slows the progression in some patients. Under the new grant, 40 Parkinson's patients now under treatment at the Columbia-Presbyterian Medical Center in New York will be evaluated to determine the exact extent of their disease. They will be videotaped and their movements measured by computer The patients also will undergo a brain imaging technique called PET at the North Shore University Hospital on Long Island. The technique measures the function of the brain cells that produce dopamine. The patients then will get fetal tissue transplants at the University of Colorado health Sciences Center in Denver, a pioneer in the transplants. During the ban, researchers there injected fetal brain cells into 16 Parkinson's patients. Colorado scientists reported last November that about a third improved significantly, a third showed some improvement and a third had no measurable benefit. "Some of them were dramatically better," said Dr. Curt Freed, head of the Colorado project. Some recovered their ability to speak and to drive cars and some who were home-bound invalids were able to travel," said Freed. In the new study, Freed said only half of the patients will actually receive fetal tissue implants. The others will receive placebos or fake injections. Neither the patients nor the doctors will know who gets the fetal tissue. The procedure will enable for the first time a precise measurement of the effects of fetal tissue transplants. Previously, no patients would {agree to help pay for such a study since only half of them actually received transplants," Freed said. Tissue used in the transplants comes from fetuses aborted after seven to eight weeks of gestation when the fetus is about an inch long. Doctors then remove a brain structure about the size of a grain of rice and extract about a half million cells to be injected into brains of the patients. Freed said the target of t he injections are two structures -- one on each side of the brain -- that are called putamen. These structures are about the size of the last thumb joint and are the source of dopamine. Eight injections will be made into each putamen in each patient. End - Paul Recer (AP) <MORE> This is a very important first step into federal funding of fetal tissue transplantation. According to Dr. Matt Kurth of the Barrow Neurological Institute in Phoenix, AZ, the federal government prefers a double blind, placebo controlled study of this nature before it will consider further research funding. Once this study has been successfully completed proposals for studying enhancements and alternatives to existing procedures can be considered. Most studies of this nature cost about $15 million and involve many patients. (DATATOP involved 800 patients.) This study involves only forty patients and at one third the cost. This study has been carefully designed, possibly over designed, to assure proposed federal guidelines in tissue accusation are used. According to Dr. William Langston, President of The Parkinson's Institute in Sunnyvale, CA, the scientific design of this research study sets a new standard in medical research. Very careful controls have been included to rem ove any bias in the evaluation. An obvious example is that Dr. Stanley Fahn will be doing the evaluation of Dr. Curt Freed's surgical results. This removes any implied bias that Dr. Freed's group would have if they were to perform the post surgical evaluations. Jim Maurer of the YPSN of Massachusetts recently interviewed Dr. Curt Freed. The full interview will be published in the Young and the Restless, the newsletter of YPSN of MA. Dr. Curt Freed's transplant history shows that one third of his fetal tissue transplant patients show great results, one third are showing marginal results and one third are showing no appreciable change. For patients under 60, the success rate is better than for those over 60. Also for patients with complications like dementia or other psychiatric problems this surgery could be harmful. Thus patient selection will be carefully controlled. There is a very large placebo effect in transplantation therapy. It has been estimated that patients can actually have improvements in their symptoms for as long as six months, yet have received nothing more than a lot of good attention. This often shows in pill studies. The study's duration of one year and other design considerations hope to minimize the placebo effect or at lease allow researchers to identify it and reduce its influence on the study results. My hat is off to those patients who are willing to participate in this study. Dr. Fahn had discussed this study with a number of patients for their input. Initially, he said, there was concern about not all getting the fetal tissue transplantation. But there is a pot of gold at the end of their rainbow. Those patients receiving the placebo will be given a fetal tissue transplantation by Dr. Curt Freed's group at the end of the study. The burr hole previously drilled will be the site of the real transplant this time. And all this is at no cost to the participant. Considering the patients condition, the fact that all will have access to the transplantation in the end and all at no cost, the patients agreed that the conditions were acceptable. All of these considerations do not change the participant's expectations. We as patients and/or caregivers always set our expectations at full recovery from PD. This can't be changed, we all want freedom from the bondage of Parkinson' s disease. Knowing that all will have the fetal tissue transplant available in the end will help resolve many of the emotional problems of waiting. Finally this study will determine a lot of the future of not just fetal tissue transplantation, but almost all forms of transplantation surgery including genetic re-engineering of our own cells for transplantation. For over five years, this promising research has been banned. Time has been lost. This study is a one year study. Lets get on with this study so that federal funding of the many proposed studies surrounding this therapy can also get funded. End of Message.....